<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is increasing evidence that focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> produces remote functional alterations that may substantially contribute to the post-<z:hpo ids='HP_0001297'>stroke</z:hpo> neurological outcome </plain></SENT>
<SENT sid="1" pm="."><plain>Changes initially limited to peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> areas may evolve and spread via transneuronal connections to other structures </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study we investigated whether focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> produced by 2-h occlusion of the middle cerebral artery (MCAo) in SD rats may influence the physiological function of the hippocampus </plain></SENT>
<SENT sid="3" pm="."><plain>Three days later in vitro long-term potentiation (LTP) was studied in hippocampal slices from ipsi- and contralateral hemispheres </plain></SENT>
<SENT sid="4" pm="."><plain>In rats with MCAo LTP was not-inducible in the ipsilateral hippocampus, while the contralateral side expressed stable potentiation (6.6+/-4.1 vs. 35 </plain></SENT>
<SENT sid="5" pm="."><plain>0+/-8.0%, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>Treatment with 6-h i.v. infusion of an uncompetitive <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> MRZ 2/579 starting at reperfusion not only preserved but additionally enhanced ipsilateral LTP, while a slight insignificant decrease was observed in the contralateral side (77.0+/-18.4 vs. 20.8+/-6.5%) </plain></SENT>
<SENT sid="7" pm="."><plain>The study demonstrates post-<z:hpo ids='HP_0001297'>stroke</z:hpo> functional changes in the hippocampus that can be modulated by <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> </plain></SENT>
</text></document>